A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study.
Arthritis Res Ther
; 24(1): 208, 2022 08 25.
Article
em En
| MEDLINE
| ID: mdl-36008814
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Gota
Limite:
Humans
/
Male
Idioma:
En
Ano de publicação:
2022